Cytokine inhibitors claimed by Novo Nordisk for diabetes and other disorders March 30, 1998 No Comments
Senetek will present additional INVICORP clinical data at AUA annual meeting March 30, 1998 No Comments
Combination therapy incorporating troglitazone leads to efficient control of type II diabetes March 27, 1998 No Comments
RSS